Abstract
OBJECTIVE: To compare the curative effects of heat-sensitive moxibustion with conventional drugs on chronic persistent asthma and seek avaluable therapy to replace Western Medicine.
METHODS: The participants in this multi-center, randomized, and controlled study were randomly divided into two groups: group A (n=144), treated with heat-sensitive moxibustion (50 sessions) and group B (n=144), treated with Seretide (salmeterol 50 μg/fluticasone 250 μg, twice a day). The scores of asthma control test (ACT), forced expiratory volume in 1 second (FEV1), peak expiratory flow (PEF), and attack frequency were measured after 15, 30, 60, and 90 days of treatment. Patients followed up 3and6monthsaftertreatment.
RESULTS: There was a significant difference (P= 0.0002) in the ACT score and lung function between the two groups after 3 months of treatment and (P=0.000 03) during the follow-up visits. In addition, heat-sensitive moxibustion reduced attack frequency in the period from inclusion to the 6-monthfollow-upvisit.
CONCLUSION: This study shows that heat-sensitive moxibustion may have a comparable curative effect to Seretide(salmeterol/fluticasone) on asthma.
Authors: Rixin Chen, Mingren Chen, Jun Xiong, Zhenhai Chi, Bo Zhang, Ning Tian, Zhenhua Xu, Tangfa Zhang, Wanyao Li, Wei Zhang,Xiaofeng Rong, Zhen Wang, Gang Sun, Baohe Ge, Guoxiong Yu,Nanchang Song
Quelel: JTraditChinMed2013October15;33(5):584-591 info@journaltcm.com